Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Arthritis Research UK Gout Treatment Trial. Phase 2: Two Year Randomised Controlled Trial of a Nurse Led Package of Care
Brief Summary: The purpose of this study is to determine in community-derived patients with gout the effectiveness, and cost effectiveness, of a nurse-led complex intervention that reflects recommended best practice (including patient information concerning gout, its prognosis and its non-pharmacological and drug options).


Options:
A: Arm Label: Nurse intervention; Type: OTHER; Interventions: Other: Nurse intervention | Arm Label: Standard care; Type: OTHER; Interventions: Other: Standard care | Intervention Type: OTHER; Name: Nurse intervention; Assigned to Arm(s): Nurse intervention | Intervention Type: OTHER; Name: Standard care; Assigned to Arm(s): Standard care
B: Arm Label: lesinurad 200 mg + allopurinol; Type: EXPERIMENTAL; Interventions: Drug: Lesinurad, Drug: Allopurinol | Arm Label: lesinurad 400 mg + allopurinol; Type: EXPERIMENTAL; Interventions: Drug: Lesinurad, Drug: Allopurinol | Arm Label: Placebo + allopurinol; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo, Drug: Allopurinol | Intervention Type: DRUG; Name: Lesinurad; Assigned to Arm(s): lesinurad 200 mg + allopurinol | Intervention Type: DRUG; Name: Lesinurad; Assigned to Arm(s): lesinurad 400 mg + allopurinol | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): Placebo + allopurinol | Intervention Type: DRUG; Name: Allopurinol; Assigned to Arm(s): lesinurad 200 mg + allopurinol | Intervention Type: DRUG; Name: Allopurinol; Assigned to Arm(s): lesinurad 400 mg + allopurinol | Intervention Type: DRUG; Name: Allopurinol; Assigned to Arm(s): Placebo + allopurinol
C: Arm Label: RDEA3170 2.5 mg, 7.5 mg and 15 mg; Type: EXPERIMENTAL; Interventions: Drug: RDEA3170 2.5 mg, Drug: allopurinol 300 mg | Arm Label: RDEA3170 5 mg, 10 mg and 20 mg; Type: EXPERIMENTAL; Interventions: Drug: RDEA3170 2.5 mg, Drug: allopurinol 300 mg | Intervention Type: DRUG; Name: RDEA3170 2.5 mg; Assigned to Arm(s): RDEA3170 2.5 mg, 7.5 mg and 15 mg, RDEA3170 5 mg, 10 mg and 20 mg | Intervention Type: DRUG; Name: allopurinol 300 mg; Assigned to Arm(s): RDEA3170 2.5 mg, 7.5 mg and 15 mg, RDEA3170 5 mg, 10 mg and 20 mg
D: Arm Label: Allopurinol / Sham Comparator (Febuxostat); Type: ACTIVE_COMPARATOR; Interventions: Drug: allopurinol capsule, 100-800 mg by mouth once daily, Drug: Placebo, vehicle control (febuxostat-shaped) | Arm Label: Febuxostat / Sham Comparator (Allopurinol); Type: ACTIVE_COMPARATOR; Interventions: Drug: febuxostat tablet 40-120 mg by mouth once daily, Drug: Placebo, vehicle control (allopurinol-shaped) | Intervention Type: DRUG; Name: allopurinol capsule, 100-800 mg by mouth once daily; Assigned to Arm(s): Allopurinol / Sham Comparator (Febuxostat) | Intervention Type: DRUG; Name: febuxostat tablet 40-120 mg by mouth once daily; Assigned to Arm(s): Febuxostat / Sham Comparator (Allopurinol) | Intervention Type: DRUG; Name: Placebo, vehicle control (febuxostat-shaped); Assigned to Arm(s): Allopurinol / Sham Comparator (Febuxostat) | Intervention Type: DRUG; Name: Placebo, vehicle control (allopurinol-shaped); Assigned to Arm(s): Febuxostat / Sham Comparator (Allopurinol)

Answer: A